LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 85

Search options

  1. Article ; Online: Prefusion stabilization of the Hendra and Langya virus F proteins.

    Byrne, Patrick O / Blade, Elizabeth G / Fisher, Brian E / Ambrozak, David R / Ramamohan, Ajit R / Graham, Barney S / Loomis, Rebecca J / McLellan, Jason S

    Journal of virology

    2024  Volume 98, Issue 2, Page(s) e0137223

    Abstract: Nipah virus (NiV) and Hendra virus (HeV) are pathogenic paramyxoviruses that cause mild-to-severe disease in humans. As members of ... ...

    Abstract Nipah virus (NiV) and Hendra virus (HeV) are pathogenic paramyxoviruses that cause mild-to-severe disease in humans. As members of the
    MeSH term(s) Humans ; Glycoproteins/metabolism ; Hendra Virus/physiology ; Henipavirus/physiology ; Henipavirus Infections ; Nipah Virus/genetics ; Nipah Virus/metabolism ; Peptides/metabolism ; Viral Fusion Proteins ; Viral Proteins/metabolism
    Chemical Substances Glycoproteins ; Peptides ; Viral Fusion Proteins ; Viral Proteins
    Language English
    Publishing date 2024-01-12
    Publishing country United States
    Document type Journal Article
    ZDB-ID 80174-4
    ISSN 1098-5514 ; 0022-538X
    ISSN (online) 1098-5514
    ISSN 0022-538X
    DOI 10.1128/jvi.01372-23
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Multilevel human secondary lymphoid immune system compartmentalization revealed by complementary imaging approaches.

    Oyler, Benjamin L / Valencia-Dávila, Jeferson A / Moysi, Eirini / Molyvdas, Adam / Ioannidou, Kalliopi / March, Kylie / Ambrozak, David / De Leval, Laurence / Fabozzi, Giulia / Woods, Amina S / Koup, Richard A / Petrovas, Constantinos

    iScience

    2023  Volume 26, Issue 8, Page(s) 107261

    Abstract: Secondary human lymphoid tissue immune reactions take place in a highly coordinated environment with compartmentalization representing a fundamental feature of this organization. ...

    Abstract Secondary human lymphoid tissue immune reactions take place in a highly coordinated environment with compartmentalization representing a fundamental feature of this organization.
    Language English
    Publishing date 2023-07-03
    Publishing country United States
    Document type Journal Article
    ISSN 2589-0042
    ISSN (online) 2589-0042
    DOI 10.1016/j.isci.2023.107261
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Structural basis for antibody recognition of vulnerable epitopes on Nipah virus F protein.

    Byrne, Patrick O / Fisher, Brian E / Ambrozak, David R / Blade, Elizabeth G / Tsybovsky, Yaroslav / Graham, Barney S / McLellan, Jason S / Loomis, Rebecca J

    Nature communications

    2023  Volume 14, Issue 1, Page(s) 1494

    Abstract: Nipah virus (NiV) is a pathogenic paramyxovirus that causes fatal encephalitis in humans. Two envelope glycoproteins, the attachment protein (G/RBP) and fusion protein (F), facilitate entry into host cells. Due to its vital role, NiV F presents an ... ...

    Abstract Nipah virus (NiV) is a pathogenic paramyxovirus that causes fatal encephalitis in humans. Two envelope glycoproteins, the attachment protein (G/RBP) and fusion protein (F), facilitate entry into host cells. Due to its vital role, NiV F presents an attractive target for developing vaccines and therapeutics. Several neutralization-sensitive epitopes on the NiV F apex have been described, however the antigenicity of most of the F protein's surface remains uncharacterized. Here, we immunize mice with prefusion-stabilized NiV F and isolate ten monoclonal antibodies that neutralize pseudotyped virus. Cryo-electron microscopy reveals eight neutralization-sensitive epitopes on NiV F, four of which have not previously been described. Novel sites span the lateral and basal faces of NiV F, expanding the known library of vulnerable epitopes. Seven of ten antibodies bind the Hendra virus (HeV) F protein. Multiple sequence alignment suggests that some of these newly identified neutralizing antibodies may also bind F proteins across the Henipavirus genus. This work identifies new epitopes as targets for therapeutics, provides a molecular basis for NiV neutralization, and lays a foundation for development of new cross-reactive antibodies targeting Henipavirus F proteins.
    MeSH term(s) Humans ; Animals ; Mice ; Nipah Virus/metabolism ; Epitopes ; Cryoelectron Microscopy ; Viral Envelope Proteins ; Antibodies, Neutralizing/metabolism ; Antibodies, Monoclonal ; Henipavirus Infections
    Chemical Substances Epitopes ; Viral Envelope Proteins ; Antibodies, Neutralizing ; Antibodies, Monoclonal
    Language English
    Publishing date 2023-03-17
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-023-36995-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Rhesus macaque Bcl-6/Bcl-xL B cell immortalization: Discovery of HIV-1 neutralizing antibodies from lymph node.

    Samsel, Jakob / Boswell, Kristin L / Watkins, Timothy / Ambrozak, David R / Mason, Rosemarie / Yamamoto, Takuya / Ko, Sungyoul / Yang, Yongping / Zhou, Tongqing / Doria-Rose, Nicole A / Foulds, Kathryn E / Roederer, Mario / Mascola, John R / Kwong, Peter D / Gama, Lucio / Koup, Richard A

    Journal of immunological methods

    2023  Volume 516, Page(s) 113445

    Abstract: Many HIV-1 vaccines are designed to elicit neutralizing antibodies, and pre-clinical testing is often carried out in rhesus macaques (RMs). We have therefore adapted a method of B cell immortalization for use with RM B cells. In this system, RM B cells ... ...

    Abstract Many HIV-1 vaccines are designed to elicit neutralizing antibodies, and pre-clinical testing is often carried out in rhesus macaques (RMs). We have therefore adapted a method of B cell immortalization for use with RM B cells. In this system, RM B cells are activated with CD40 ligand and RM IL-21 before transduction with a retroviral vector encoding Bcl-6, Bcl-xL, and green fluorescent protein. Importantly, RM B cells from lymph nodes are more effectively immortalized by this method than B cells from PBMC, a difference not seen in humans. We suggest the discrepancy between these two tissues is due to increased expression of CD40 on RM lymph node B cells. Immortalized RM B cells expand long-term, undergo minimal somatic hypermutation, express surface B cell receptor, and secrete antibodies into culture. This allows for the identification of cells based on antigen specificity and/or functional assays. Here, we show the characterization of this system and its application for the isolation of HIV-1 neutralizing antibodies from a SHIV.CH505-infected animal, both with and without antigen probe. Taken together, we show that Bcl-6/xL immortalization is a valuable and flexible tool for antibody discovery in RMs, but with important distinctions from application of the system in human cells.
    MeSH term(s) Animals ; Humans ; Macaca mulatta ; HIV-1 ; Leukocytes, Mononuclear ; HIV Antibodies ; Antibodies, Neutralizing ; AIDS Vaccines ; Lymph Nodes ; Simian Immunodeficiency Virus ; Simian Acquired Immunodeficiency Syndrome
    Chemical Substances HIV Antibodies ; Antibodies, Neutralizing ; AIDS Vaccines
    Language English
    Publishing date 2023-02-25
    Publishing country Netherlands
    Document type Journal Article ; Research Support, N.I.H., Intramural
    ZDB-ID 120142-6
    ISSN 1872-7905 ; 0022-1759
    ISSN (online) 1872-7905
    ISSN 0022-1759
    DOI 10.1016/j.jim.2023.113445
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Rhesus macaque Bcl-6/Bcl-xL B cell immortalization: Discovery of HIV-1 neutralizing antibodies from lymph node

    Samsel, Jakob / Boswell, Kristin L. / Baron / Ambrozak, David R. / Mason, Rosemarie / Yamamoto, Takuya / Ko, Sungyoul / Yang, Yongping / Zhou, Tongqing / Doria-Rose, Nicole A. / Foulds, Kathryn E. / Roederer, Mario / Mascola, John R. / Kwong, Peter D. / Gama, Lucio / Koup, Richard A.

    Journal of Immunological Methods. 2023 May, v. 516 p.113445-

    2023  

    Abstract: Many HIV-1 vaccines are designed to elicit neutralizing antibodies, and pre-clinical testing is often carried out in rhesus macaques (RMs). We have therefore adapted a method of B cell immortalization for use with RM B cells. In this system, RM B cells ... ...

    Abstract Many HIV-1 vaccines are designed to elicit neutralizing antibodies, and pre-clinical testing is often carried out in rhesus macaques (RMs). We have therefore adapted a method of B cell immortalization for use with RM B cells. In this system, RM B cells are activated with CD40 ligand and RM IL-21 before transduction with a retroviral vector encoding Bcl-6, Bcl-xL, and green fluorescent protein. Importantly, RM B cells from lymph nodes are more effectively immortalized by this method than B cells from PBMC, a difference not seen in humans. We suggest the discrepancy between these two tissues is due to increased expression of CD40 on RM lymph node B cells. Immortalized RM B cells expand long-term, undergo minimal somatic hypermutation, express surface B cell receptor, and secrete antibodies into culture. This allows for the identification of cells based on antigen specificity and/or functional assays. Here, we show the characterization of this system and its application for the isolation of HIV-1 neutralizing antibodies from a SHIV.CH505-infected animal, both with and without antigen probe. Taken together, we show that Bcl-6/xL immortalization is a valuable and flexible tool for antibody discovery in RMs, but with important distinctions from application of the system in human cells.
    Keywords B-lymphocytes ; Macaca mulatta ; antibodies ; antigens ; green fluorescent protein ; humans ; interleukin-21 ; ligands ; lymph ; lymph nodes ; retroviral vectors ; Antibody discovery ; B cell immortalization ; HIV ; Vaccination ; Rhesus macaque
    Language English
    Dates of publication 2023-05
    Publishing place Elsevier B.V.
    Document type Article ; Online
    ZDB-ID 120142-6
    ISSN 1872-7905 ; 0022-1759
    ISSN (online) 1872-7905
    ISSN 0022-1759
    DOI 10.1016/j.jim.2023.113445
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  6. Article ; Online: Interaction dynamics between innate and adaptive immune cells responding to SARS-CoV-2 vaccination in non-human primates.

    Schramm, Chaim A / Moon, Damee / Peyton, Lowrey / Lima, Noemia S / Wake, Christian / Boswell, Kristin L / Henry, Amy R / Laboune, Farida / Ambrozak, David / Darko, Samuel W / Teng, I-Ting / Foulds, Kathryn E / Carfi, Andrea / Edwards, Darin K / Kwong, Peter D / Koup, Richard A / Seder, Robert A / Douek, Daniel C

    Nature communications

    2023  Volume 14, Issue 1, Page(s) 7961

    Abstract: As SARS-CoV-2 variants continue evolving, testing updated vaccines in non-human primates remains important for guiding human clinical practice. To date, such studies have focused on antibody titers and antigen-specific B and T cell frequencies. Here, we ... ...

    Abstract As SARS-CoV-2 variants continue evolving, testing updated vaccines in non-human primates remains important for guiding human clinical practice. To date, such studies have focused on antibody titers and antigen-specific B and T cell frequencies. Here, we extend our understanding by integrating innate and adaptive immune responses to mRNA-1273 vaccination in rhesus macaques. We sorted innate immune cells from a pre-vaccine time point, as well as innate immune cells and antigen-specific peripheral B and T cells two weeks after each of two vaccine doses and used single-cell sequencing to assess the transcriptomes and adaptive immune receptors of each cell. We show that a subset of S-specific T cells expresses cytokines critical for activating innate responses, with a concomitant increase in CCR5-expressing intermediate monocytes and a shift of natural killer cells to a more cytotoxic phenotype. The second vaccine dose, administered 4 weeks after the first, elicits an increase in circulating germinal center-like B cells 2 weeks later, which are more clonally expanded and enriched for epitopes in the receptor binding domain. Both doses stimulate inflammatory response genes associated with elevated antibody production. Overall, we provide a comprehensive picture of bidirectional signaling between innate and adaptive components of the immune system and suggest potential mechanisms for the enhanced response to secondary exposure.
    MeSH term(s) Animals ; Humans ; COVID-19 Vaccines ; Macaca mulatta ; SARS-CoV-2 ; COVID-19/prevention & control ; Vaccination ; Blood Group Antigens ; Antibodies, Viral
    Chemical Substances COVID-19 Vaccines ; Blood Group Antigens ; Antibodies, Viral
    Language English
    Publishing date 2023-12-02
    Publishing country England
    Document type Journal Article
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-023-43420-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Vaccine elicitation and structural basis for antibody protection against alphaviruses

    Sutton, Matthew S. / Pletnev, Sergei / Callahan, Victoria / Ko, Sungyoul / Tsybovsky, Yaroslav / Bylund, Tatsiana / Casner, Ryan G. / Cerutti, Gabriele / Gardner, Christina L. / Guirguis, Veronica / Verardi, Raffaello / Zhang, Baoshan / Ambrozak, David / Beddall, Margaret / Lei, Hong / Yang, Eun Sung / Liu, Tracy / Henry, Amy R. / Rawi, Reda /
    Schön, Arne / Schramm, Chaim A. / Shen, Chen-Hsiang / Shi, Wei / Stephens, Tyler / Yang, Yongping / Florez, Maria Burgos / Ledgerwood, Julie E. / Burke, Crystal W. / Shapiro, Lawrence / Fox, Julie M. / Kwong, Peter D. / Roederer, Mario

    Cell. 2023 June, v. 186, no. 12 p.2672-2689.e25

    2023  

    Abstract: Alphaviruses are RNA viruses that represent emerging public health threats. To identify protective antibodies, we immunized macaques with a mixture of western, eastern, and Venezuelan equine encephalitis virus-like particles (VLPs), a regimen that ... ...

    Abstract Alphaviruses are RNA viruses that represent emerging public health threats. To identify protective antibodies, we immunized macaques with a mixture of western, eastern, and Venezuelan equine encephalitis virus-like particles (VLPs), a regimen that protects against aerosol challenge with all three viruses. Single- and triple-virus-specific antibodies were isolated, and we identified 21 unique binding groups. Cryo-EM structures revealed that broad VLP binding inversely correlated with sequence and conformational variability. One triple-specific antibody, SKT05, bound proximal to the fusion peptide and neutralized all three Env-pseudotyped encephalitic alphaviruses by using different symmetry elements for recognition across VLPs. Neutralization in other assays (e.g., chimeric Sindbis virus) yielded variable results. SKT05 bound backbone atoms of sequence-diverse residues, enabling broad recognition despite sequence variability; accordingly, SKT05 protected mice against Venezuelan equine encephalitis virus, chikungunya virus, and Ross River virus challenges. Thus, a single vaccine-elicited antibody can protect in vivo against a broad range of alphaviruses.
    Keywords Chikungunya virus ; RNA ; Ross River virus ; Sindbis virus ; Venezuelan equine encephalitis virus ; aerosols ; antibodies ; encephalitis ; genetic variation ; horses ; neutralization ; peptides ; public health ; vaccines ; alphavirus ; broadly neutralizing antibody ; cryo-EM ; in vivo challenge ; vaccine
    Language English
    Dates of publication 2023-06
    Size p. 2672-2689.e25.
    Publishing place Elsevier Inc.
    Document type Article ; Online
    ZDB-ID 187009-9
    ISSN 1097-4172 ; 0092-8674
    ISSN (online) 1097-4172
    ISSN 0092-8674
    DOI 10.1016/j.cell.2023.05.019
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  8. Article ; Online: Vaccine Generation of Protective Ebola Antibodies and Identification of Conserved B-Cell Signatures.

    Cagigi, Alberto / Misasi, John / Ploquin, Aurélie / Stanley, Daphne A / Ambrozak, David / Tsybovsky, Yaroslav / Mason, Rosemarie D / Roederer, Mario / Sullivan, Nancy J

    The Journal of infectious diseases

    2018  Volume 218, Issue suppl_5, Page(s) S528–S536

    Abstract: We recently identified a single potently neutralizing monoclonal antibody (mAb), mAb114, isolated from a human survivor of natural Zaire ebolavirus (EBOV) infection, which fully protects nonhuman primates (NHPs) against lethal EBOV challenge. To evaluate ...

    Abstract We recently identified a single potently neutralizing monoclonal antibody (mAb), mAb114, isolated from a human survivor of natural Zaire ebolavirus (EBOV) infection, which fully protects nonhuman primates (NHPs) against lethal EBOV challenge. To evaluate the ability of vaccination to generate mAbs such as mAb114, we cloned antibodies from NHPs vaccinated with vectors encoding the EBOV glycoprotein (GP). We identified 14 unique mAbs with potent binding to GP, 4 of which were neutralized and had the functional characteristics of mAb114. These vaccine-induced macaque mAbs share many sequence similarities with mAb114 and use the same mAb114 VH gene (ie, IGHV3-13) when classified using the macaque IMGT database. The antigen-specific VH-gene repertoire present after each immunization indicated that IGHV3-13 mAbs populate an EBOV-specific B-cell repertoire that appears to become more prominent with subsequent boosting. These findings will support structure-based vaccine design aimed at enhanced induction of antibodies such as mAb114.
    MeSH term(s) Animals ; Antibodies, Monoclonal/immunology ; Antibodies, Neutralizing/immunology ; Antibodies, Viral/immunology ; B-Lymphocytes/immunology ; Ebola Vaccines/immunology ; Ebolavirus/immunology ; Humans ; Hydrogen-Ion Concentration ; Macaca fascicularis ; Vaccination ; Viral Envelope Proteins/immunology
    Chemical Substances Antibodies, Monoclonal ; Antibodies, Neutralizing ; Antibodies, Viral ; Ebola Vaccines ; Viral Envelope Proteins ; envelope glycoprotein, Ebola virus
    Language English
    Publishing date 2018-06-28
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, N.I.H., Intramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 3019-3
    ISSN 1537-6613 ; 0022-1899
    ISSN (online) 1537-6613
    ISSN 0022-1899
    DOI 10.1093/infdis/jiy333
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Procedures for Flow Cytometry-Based Sorting of Unfixed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Cells and Other Infectious Agents.

    Reifel, Kristen M / Swan, Brandon K / Jellison, Evan R / Ambrozak, David / Baijer, Jan / Nguyen, Richard / Monard, Simon / Lyon, Geoffrey / Fontes, Benjamin / Perfetto, Stephen P

    Cytometry. Part A : the journal of the International Society for Analytical Cytology

    2020  Volume 97, Issue 7, Page(s) 674–680

    Abstract: In response to the recent COVID-19 pandemic, many laboratories are involved in research supporting SARS-CoV-2 vaccine development and clinical trials. Flow cytometry laboratories will be responsible for a large part of this effort by sorting unfixed ... ...

    Abstract In response to the recent COVID-19 pandemic, many laboratories are involved in research supporting SARS-CoV-2 vaccine development and clinical trials. Flow cytometry laboratories will be responsible for a large part of this effort by sorting unfixed antigen-specific lymphocytes. Therefore, it is critical and timely that we have an understanding of risk assessment and established procedures of infectious cell sorting. Here we present procedures covering the biosafety aspects of sorting unfixed SARS-CoV-2-infected cells and other infectious agents of similar risk level. These procedures follow the ISAC Biosafety Committee guidelines and were recently approved by the National Institutes of Health Institutional Biosafety Committee for sorting SARS-CoV-2-infected cells. © 2020 International Society for Advancement of Cytometry.
    MeSH term(s) Betacoronavirus/isolation & purification ; COVID-19 ; Containment of Biohazards/methods ; Coronavirus Infections/diagnosis ; Coronavirus Infections/prevention & control ; Flow Cytometry/methods ; Humans ; Laboratories/standards ; Medical Laboratory Personnel/standards ; Pandemics/prevention & control ; Pneumonia, Viral/diagnosis ; Pneumonia, Viral/prevention & control ; Risk Assessment ; SARS-CoV-2 ; Specimen Handling/methods
    Keywords covid19
    Language English
    Publishing date 2020-06-03
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2099868-5
    ISSN 1552-4930 ; 0196-4763 ; 1552-4922
    ISSN (online) 1552-4930
    ISSN 0196-4763 ; 1552-4922
    DOI 10.1002/cyto.a.24040
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Acquisition of optimal TFH cell function is defined by specific molecular, positional, and TCR dynamic signatures.

    Padhan, Kartika / Moysi, Eirini / Noto, Alessandra / Chassiakos, Alexander / Ghneim, Khader / Perra, Maria Maddalena / Shah, Sanjana / Papaioannou, Vasilis / Fabozzi, Giulia / Ambrozak, David R / Poultsidi, Antigoni / Ioannou, Maria / Fenwick, Craig / Darko, Samuel / Douek, Daniel C / Sekaly, Rafick-Pierre / Pantaleo, Giuseppe / Koup, Richard A / Petrovas, Constantinos

    Proceedings of the National Academy of Sciences of the United States of America

    2021  Volume 118, Issue 18

    Abstract: The development of follicular helper CD4 T (TFH) cells is a dynamic process resulting in a heterogenous pool of TFH subsets. However, the cellular and molecular determinants of this heterogeneity and the possible mechanistic links between them is not ... ...

    Abstract The development of follicular helper CD4 T (TFH) cells is a dynamic process resulting in a heterogenous pool of TFH subsets. However, the cellular and molecular determinants of this heterogeneity and the possible mechanistic links between them is not clear. We found that human TFH differentiation is associated with significant changes in phenotypic, chemokine, functional, metabolic and transcriptional profile. Furthermore, this differentiation was associated with distinct positioning to follicular proliferating B cells. Single-cell T cell receptor (TCR) clonotype analysis indicated the transitioning toward PD-1
    MeSH term(s) CD4-Positive T-Lymphocytes/immunology ; CD57 Antigens/genetics ; Cell Communication/immunology ; Cell Differentiation/genetics ; Cell Differentiation/immunology ; Cell Lineage/genetics ; Cell Lineage/immunology ; Chemokines/genetics ; Germinal Center/immunology ; Germinal Center/metabolism ; Humans ; Immunological Synapses/genetics ; Immunological Synapses/immunology ; Lymphocyte Activation/immunology ; Phenotype ; Programmed Cell Death 1 Receptor/genetics ; Receptors, Antigen, T-Cell/genetics ; Receptors, Antigen, T-Cell/immunology ; T Follicular Helper Cells/immunology ; T Follicular Helper Cells/metabolism ; T-Lymphocyte Subsets/immunology
    Chemical Substances CD57 Antigens ; Chemokines ; PDCD1 protein, human ; Programmed Cell Death 1 Receptor ; Receptors, Antigen, T-Cell
    Language English
    Publishing date 2021-04-26
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Intramural
    ZDB-ID 209104-5
    ISSN 1091-6490 ; 0027-8424
    ISSN (online) 1091-6490
    ISSN 0027-8424
    DOI 10.1073/pnas.2016855118
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top